Upper Limb Treatment With "Gloreha Aria" in the Hemiplegic Patients

Upper Extremity Injury Clinical Trial

Official title:

Feasibility and Efficacy of the Upper Limb Treatment With "Gloreha Aria" in the Hemiplegic Patients: a Randomized Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03738813
• Other study ID #: ICS Maugeri - CE 2208
• Status: Completed
• Phase: N/A
• Start date: July 1, 2018
• Est. completion date: September 7, 2021

Study information

• Verified date: September 2021
• Source: Istituti Clinici Scientifici Maugeri SpA
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Stroke is one of the leading causes of death and disability and has been described as a worldwide epidemic (1). Stroke survivors are affected by impairments and limitations of cognitive, language, perceptual, sensory, and motor functions. After a stroke, patients can improve spontaneously within the first 3 months (2) and then more slowly in the following year. The first day, decreased oedema and partial reperfusion of the ischemic penumbra may possibly explain these phenomena, but the improvement of neurological deficit in the following weeks suggests plasticity phenomena and brain cortical reorganization (3). While most recovery is thought to be made in the first few weeks after stroke, patients may make improvements on functional tasks many months after having a stroke (4). Restoring arm and hand skill after a stroke remains challenging, even though stroke rehabilitation programs have proven partial efficacy Repetitive task training has been shown to be effective in some aspects of rehabilitation, such as improving walking distance and speed and improving upper limb function (5). In this project, the investigators will use "Gloreha ARIA" (7) a new sensor-based therapy device designed for motor recovery of impaired upper limb Gloreha Aria offers specific programs that help patients to move arm, wrist and fingers. Therapists can customize therapy by focusing on a specific motor task.

Description:

The hypothesis was that rehabilitation with this device could be not inferior in comparison with hands-on physiotherapy, in the reeducation of upper arm in the patient affected by stroke from cerebral ischemia or hemorrhage that had occurred ≤ 30 days before. The principle purpose of this study will be to evaluate: 1. The feasibility of this new device 2. Efficacy in improving arm function abilities in the rehabilitation of patients with stroke in the sub-acute phase. Post-stroke patients admitted for inpatient rehabilitation to the Neurological Rehabilitation will be screened for enrolment and randomized in a controlled trial. All the patients will be informed about the aim and experimental procedures before enrolment, thus written informed consent will be obtained from all of them. Patients included in the study will be randomly assigned to intervention or control group according to simple randomization technique (computerized random numbers).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: September 7, 2021
• Est. primary completion date: June 30, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• to exhibit first cerebral vascular disease with unilateral hemispherical lesion confirmed by CT scan or MRI;
• to be sub-acute patients (less than 30 days from the cerebral vascular event);
• being affected by upper limb paresis;

Exclusion Criteria:

1. unable to understand verbal instruction or motor commands;

2. unilateral neglect;

3. apraxia;

4. significant visual impairment;

5. unstable medical condition;

6. significant orthopedic limitation to the shoulder, elbow; wrist and hand;

7. upper arm peripherical nerve lesion;

8. neuromuscular or neurodegenerative diseases;

9. spasticity > 3 in according to the Modifies Ashworth Scale (3);

Related Conditions & MeSH terms

• Arm Injuries
• Hemiplegia
• Hemiplegia and/or Hemiparesis Following Stroke
• Paresis
• Upper Extremity Injury

Intervention

Device:
• Gloreha Aria
Device offers specific programs that help patients to move arm, wrist and fingers

Other:
• Usual care
Conventional occupational therapy

Locations

Country	Name	City	State
Italy	Istituti Clinici Scientifici Maugeri IRCCS	Pavia

Sponsors (1)

Lead Sponsor	Collaborator
Istituti Clinici Scientifici Maugeri SpA

Country where clinical trial is conducted

Italy, 

References & Publications (5)

Bennett DA, Krishnamurthi RV, Barker-Collo S, Forouzanfar MH, Naghavi M, Connor M, Lawes CM, Moran AE, Anderson LM, Roth GA, Mensah GA, Ezzati M, Murray CJ, Feigin VL; Global Burden of Diseases, Injuries, and Risk Factors 2010 Study Stroke Expert Group. The global burden of ischemic stroke: findings of the GBD 2010 study. Glob Heart. 2014 Mar;9(1):107-12. doi: 10.1016/j.gheart.2014.01.001. Review. — View Citation

Chen R, Cohen LG, Hallett M. Nervous system reorganization following injury. Neuroscience. 2002;111(4):761-73. Review. — View Citation

French B, Thomas LH, Coupe J, McMahon NE, Connell L, Harrison J, Sutton CJ, Tishkovskaya S, Watkins CL. Repetitive task training for improving functional ability after stroke. Cochrane Database Syst Rev. 2016 Nov 14;11:CD006073. Review. — View Citation

Maulden SA, Gassaway J, Horn SD, Smout RJ, DeJong G. Timing of initiation of rehabilitation after stroke. Arch Phys Med Rehabil. 2005 Dec;86(12 Suppl 2):S34-S40. — View Citation

Teasell RW, Murie Fernandez M, McIntyre A, Mehta S. Rethinking the continuum of stroke rehabilitation. Arch Phys Med Rehabil. 2014 Apr;95(4):595-6. doi: 10.1016/j.apmr.2013.11.014. Epub 2014 Feb 14. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change from baseline of FMA-UE (Fugl-Meyer assessment upper extremity).	Assessment of sensorimotor function.	From date of randomization (T0) until the to the end of the study (T1) after an intervention lasting over a period of about 6 weeks, assessed after 30 rehabilitation sessions, lasting 30 min/ day each and performed 5 days/week.

External Links

•   Brochure of Gloreha ARIA device